Self-Assembling Matrix Forming Gel to Prevent Stricture Formation

Completed

Conditions studied: Esophageal Stricture, Stricture

In brief

The study is designed as a multicenter prospective registry study evaluating the efficacy of the self-assembling peptide in the prevention of stricture formation after endoscopic resection as part of standard medical care. No experimental interventions will be performed.

Key facts

Study ID

NCT05581173

Run by

AdventHealth

People needed

41

Starts

2022-09-19

Expected to finish

2025-01-23

Last updated by the study team

2025-01-24

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age 18 years or older
• Patients at high-risk for esophageal stricture formation defined as undergoing endoscopic resection in the esophagus involving more than 50% of the circumference

You may not qualify if…

• Any standard contraindication to anesthesia and/or endoscopy
• Participation in another research protocol that could interfere or influence the outcomes measures of the present study.

Where it is running

• AdventHealth Orlando — Orlando, Florida, United States
• Parkview — Fort Wayne, Indiana, United States
• Johns Hopkins — Baltimore, Maryland, United States
• Beth Israel Deaconess Medical Center — Boston, Massachusetts, United States
• Columbia University Irving Medical Center — New York, New York, United States
• Baylor St. Lukes — Houston, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.